Analysis reveals challenges in data acquisition and analytical methods for Global Burden of Disease 2023, suggesting improved accuracy and external validity are needed.
The Global Burden of Disease 2023 represents the most comprehensive iteration of its kind since first reported in 1993. Despite improved health monitoring, data acquisition, and analytical methods, its expansion creates new challenges and opportunities for improving its accuracy, completeness, external validity, and policy relevance.
No takes yet. Share an insight, caveat, or question.
Zulfiqar A. Bhutta (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: